Response letter to "Use, response and outcomes of second-line chemotherapy in patients with advanced biliary tract cancers"

被引：0
|
作者：
Ichimura, Takenori [1 ,2 ]
机构：
[1] Univ Sch Pharm, Dept Hosp Pharmaceut, Tokyo, Japan
[2] Showa Univ, Dept Hosp Pharmaceut, Sch Pharm, 1-5-8 Hatanodai,Shinagawa Ku, Tokyo 1428555, Japan
来源：
JOURNAL OF ONCOLOGY PHARMACY PRACTICE | 2023年 / 29卷 / 04期
关键词：
GEMCITABINE; CISPLATIN;
D O I：
10.1177/10781552231165235
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1025 / 1026
页数：2
相关论文
共 50 条
  • [11] SECOND-LINE CHEMOTHERAPY IN ADVANCED BILIARY TRACT CANCER: A RETROSPECTIVE SERIES
    Brungs, Daniel
    Aghmesheh, Morteza
    Sjoquist, Katrin
    Goldstein, David
    Asia-Pacific Journal of Clinical Oncology, 2015, 11 : 168 - 168
  • [12] Second-line chemotherapy in patients with biliary tract cancer.
    Brandi, G.
    Di Girolamo, S.
    de Rosa, F.
    Corbelli, J.
    Agostini, V.
    Garajova, I.
    Longobardi, C.
    Paragona, M.
    Ercolani, G.
    Pinna, A. D.
    Biasco, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [13] Real-world outcomes among patients with advanced or metastatic biliary tract cancers initiating second-line treatment
    Cosgrove, David P.
    Reese, Emily S.
    Fulcher, Nicole M.
    Bobiak, Sarah S.
    Lamy, Francois-Xavier
    Allignol, Arthur
    Boyd, Marley
    Mahmoudpour, Seyed H.
    CANCER MEDICINE, 2023, 12 (04): : 4195 - 4205
  • [14] Capecitabine and Celecoxib as Second-Line Treatment of Advanced Pancreatic and Biliary Tract Cancers
    Pino, Maria S.
    Milella, Michele
    Gelibter, Alain
    Sperduti, Isabella
    De Marco, Salvatore
    Nuzzo, Carmen
    Bria, Emilio
    Carpanese, Livio
    Ruggeri, Enzo M.
    Carlini, Paolo
    Cognetti, Francesco
    ONCOLOGY, 2009, 76 (04) : 254 - 261
  • [15] Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis.
    Goff, Laura Williams
    Lowery, Maeve Aine
    Jordan, Emmet
    Wang, Rui
    Bocobo, Andrea Grace
    Chou, Joanne F.
    O'Reilly, Eileen Mary
    Harding, James J.
    Kemeny, Nancy E.
    Capanu, Marinela
    Griffin, Ann C.
    McGuire, Joseph P.
    Venook, Alan P.
    Abou-Alfa, Ghassan K.
    Kelley, Robin Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [16] Second-line chemotherapy (CTx) outcomes in advanced biliary cancers (ABC): A retrospective multicenter analysis.
    Lowery, Maeve Aine
    Goff, Laura Williams
    Jordan, Emmet
    Wang, Rui
    Bocobo, Andrea Grace
    Chou, Joanne F.
    O'Reilly, Eileen Mary
    Harding, James J.
    Kemeny, Nancy E.
    Capanu, Marinela
    Griffin, Ann
    McGuire, Joseph P.
    Venook, Alan P.
    Abou-Alfa, Ghassan K.
    Kelley, Robin Kate
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [17] Benefit of second-line chemotherapy in patients with advanced biliary tract cancer: A propensity score analysis
    Thanasombunsukh, Kijjakom
    Khorana, Jiraporn
    Tantraworasin, Apichat
    Charoentum, Chaiyut
    ANNALS OF ONCOLOGY, 2022, 33 : S496 - S496
  • [18] Prognostic Factors for the Selection of Patients Eligible for Second-Line Chemotherapy in Advanced Biliary Tract Cancer
    Kang, Eun Joo
    Choi, Yoon Ji
    Kim, Jung Sun
    Park, Kyong Hwa
    Oh, Sang Chul
    Seo, Jae Hong
    Kim, Hong Jun
    Kang, Ka-Won
    Yu, Eun Sang
    Shin, Sang W.
    Kim, Yeul H.
    Kim, Jun Suk
    CHEMOTHERAPY, 2014, 60 (02) : 91 - 98
  • [19] Prognostic factor analysis of second-line chemotherapy in advanced biliary tract cancer
    Lee, Sang-Cheol
    Kim, Kyoungha
    Kim, Hanjo
    Kim, Hyun Jung
    Kim, Se Hyung
    Bae, Sang-Byung
    Kim, Chan Kyu
    Lee, Namsu
    Lee, Kyu Taek
    Park, Sung Kyu
    Won, Jong-Ho
    Yun, Jina
    Hong, Dae Sik
    Park, Hee Sook
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [20] Second-line chemotherapy for advanced biliary tract cancer: Results of a multicenter survey
    Vasile, E.
    Di Girolamo, S.
    Cereda, S.
    Lonardi, S.
    Leone, F.
    Russano, M.
    Silvestris, N.
    Vivaldi, C.
    Fornaro, L.
    Brandi, G.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S614 - S614
12345